Search / 497 results found Showing: 1-10 of 497
This week, the U.S. Food and Drug Administration approved a new treatment for osteoarthritis in cats, marking the first time a monoclonal antibody drug has been FDA approved for treatment of animal diseases.
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of Jan. 10 to 14, 2022. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
FRIDAY, Jan. 14, 2022 (HealthDay News) -- For years, researchers have suspected that the Epstein-Barr virus, best known for causing mononucleois, might also play a role in triggering multiple sclerosis. Now a new study strengthens the case.
FRIDAY, Jan. 14, 2022 (HealthDay News) -- As the Omicron variant rages across the United States, an expert outlines how to reduce your risk of getting infected with COVID-19.
THURSDAY, Jan. 13, 2022 (HealthDay News) -- Arthritis can keep a cat from doing many of the things that kitties love to do. But now there's hope: The first treatment to ease arthritis pain in cats has been approved by the U.S. Food and Drug Administration.
THURSDAY, Jan. 13, 2022 (HealthDay News) -- Real-world use shows the Woven EndoBridge (WEB) device is safe and effective for treating brain aneurysms, according to a research letter published online Dec. 17 in Stroke.
THURSDAY, Jan. 13, 2022 (American Heart Association News) -- Anyone who has put on a few too many pounds knows they can slow you down. Over time, if those pounds grow into obesity, they may do serious harm, putting you at risk for a wide range of illnesses.
THURSDAY, Jan. 13, 2022 (American Heart Association News) -- "Mommy, I'm tired" became a common refrain from usually peppy 7-year-old Olivia Story to her mother, Jennifer.